Money

More than 500 Scottish jobs announced at £78 million global research hub



More than 500 new jobs are to be created as part of plans to establish a global health research, development and manufacturing hub.

Life sciences giant LumiraDx has announced a £78m investment in its current Scottish operations, with 510 new posts guaranteed over the next three years as a result.

The firm is hopeful this could rise to more than 750 new posts if current market demand prevails.

Supported by a £15m grant from Scottish Enterprise, the posts will be located at sites across Stirling, Inverness and a new facility under construction at Eurocentral, near Glasgow.

The company’s rapid antigen test for coronavirus is currently being used by the NHS.

The new jobs will scale up manufacturing, as well as the development of a range of other ground-breaking tests.

The firm currently has a pipeline of 30 tests for conditions including blood clots, heart disease, and diabetes.

Economy Secretary Fiona Hyslop said: “Life sciences has been a cornerstone of our economy for many years and this announcement shows that the sector will continue to drive growth in the future and help in the fight against the pandemic.

“The fact that hundreds of high-quality research jobs are being created shows that the company recognises the skills which exist in the country’s workforce.”

Up to 80% of the healthcare products manufactured by the firm will be for the export market, including the US, Europe and Japan.

LumiraDx chief executive Ron Zwanziger said: “We are pleased to contribute to Scotland’s health and economic growth, now and beyond the pandemic.

READ  Clever hacks to mend clothes, erase stains and get trainers white on a budget — plus win £50k in the Sun Raffle

“We are also delighted to be increasing our footprint in Scotland and expanding the country’s life sciences industry.

“It’s an exciting undertaking, and we know to do this quickly and to do it well we need the right infrastructure in place and access to incredible talent to drive this development – Scotland has both.

“We are proud to be investing in the country, and its communities and grateful to Scottish Enterprise for their support through this grant,” he added.

LumiraDx has more than 1,200 global employees, with sites and operations in Scotland, England, most European countries, the US, Japan, South Africa and Latin America.

It currently has five sites across Scotland with a total of 579 employees.

The grant agreed with Scottish Enterprise is contingent on the creation of 510 new jobs being created by the end of 2023.

Around 200 of the new roles will be in research and development (R&D), with the rest in high-tech manufacturing.

Many R&D roles will be graduates or postgraduates, with apprenticeships being considered for manufacturing.

LumiraDx has developed a next generation point of care diagnostic platform and tests including its high sensitivity antigen test for Covid-19, which is currently being used by the NHS in Scotland.

Don’t miss the latest headlines with our twice-daily newsletter – sign up here for free.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.